Related Experiment Video
Updated: May 8, 2026
Computed Tomography (CT) Guided Implantation of a Totally Implantable Venous Access Port (TIVAP) through Subclavian Vein
Published on: January 13, 2026
Surgical placement of totally implantable venous access device-an institutional experience
Aravindan Chandrasekaran1, Jayabose Somasundaram
1Department of Pediatric Surgery, Meenakshi Mission Hospital and Research Centre, Madurai, 625107, Tamil Nadu, India, scaravindu@gmail.com.
Insights
Totally implantable venous access devices (TIVADs) offer a useful IV access solution for pediatric patients needing long-term chemotherapy. While complications are possible, patient satisfaction remains high with this device.
Area of Science:
- Pediatric Surgery
- Oncology
- Medical Devices
Background:
- Chemotherapy requires reliable venous access in pediatric patients.
- Totally implantable venous access devices (TIVADs) are an option for long-term IV access.
Purpose of the Study:
- To evaluate the advantages and disadvantages of TIVADs in children.
- To compare findings with existing literature.
Main Methods:
- 61 pediatric patients (2 months to 14 years) received TIVADs for chemotherapy.
- Implantation was performed under general anesthesia using an open technique.
- Patients were followed for a mean of 7.2 months.
Main Results:
- 9 out of 61 patients experienced complications, including infection (3 removals) and malpositioning (1 reinsertion).
- One case of wound dehiscence required correction; four had minor wound infections.
- The open insertion technique showed low rates of pneumothorax, hemothorax, arterial puncture, and hematoma. Patient and parent satisfaction was high.
Conclusions:
- TIVADs are a beneficial device for pediatric patients requiring frequent IV access for chronic conditions.
- The open technique for TIVAD insertion in children is associated with minimal serious complications.
Objectives:
To investigate the advantages and disadvantages of Totally implantable venous access devices (TIVAD) catheter in pediatric age group and also to review this subject in the recent literature and compare the results with the present results.
Methods:
A total of 61 cases, 2 mo to 14 y old, were included in the index study. TIVADs were implanted in these patients for chemotherapy. The device was inserted under general anesthesia (GA) by open technique. All the children were followed up for a mean period of 7.2 mo.
Results:
Out of 61 cases, 9 cases had complications; 3 requiring removal of the port due to infection and in one case the device had to be reinserted due to malpositioning, one had late wound dehiscence with exposed port chamber which needed operative correction and four had minor wound infections. There was no mortality. Complications like hemo or pneumothorax, arterial puncture, hematoma formation were very less with open technique of insertion of the port. Most patients and their parents were satisfied with TIVAD.
Conclusions:
Thus, TIVAD can be a useful device for many chronic patients who need an IV access for multiple injections especially in pediatric age group.
